Stents, scaffolds and DCB

Latest Stents, scaffolds and DCB content in interventional cardiology - research, practice, and education

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

505 results

Left main interventions: pushing the boundaries

21 May 2026 – From EuroPCR 2026

Examine contemporary strategies for distal left main bifurcation disease treatment, including debates on complex bifurcation and high-risk PCI approaches. The session emphasizes the critical role of coronary imaging in guiding decision-making and showcases clinical cases illustrating management of left main interventions under challenging conditions.

Hybrid percutaneous revascularisation: combining DES and DCB for optimal results

21 May 2026 – From EuroPCR 2026

This session delves into hybrid percutaneous revascularisation techniques that combine drug-eluting stents (DES) and drug-coated balloons (DCB) to achieve optimal clinical results. It highlights the clinical and anatomical scenarios suited for hybrid PCI, provides a step-by-step procedural approach, and discusses the potential benefits of integrating these...

Refining the gold standard: what is new in DES

21 May 2026 – From EuroPCR 2026

This session explores recent advancements in drug-eluting stent (DES) technology, featuring global real-world evidence on short dual antiplatelet therapy (DAPT) with polymer-free DES, angiographic outcomes from pooled TARGET trials, and real-world registry data on various DES platforms. It also presents post-marketing surveillance results and systematic reviews...

DCB: does coating morphology matter for distal embolisation and clinical outcomes?

20 May 2026 – From EuroPCR 2026

Drug-coated balloon (DCB) therapy continues to evolve, with increasing attention on how coating design may influence drug transfer, vessel response and downstream clinical outcomes.

This EuroPCR 2026 session examines the role of coating morphology, comparing amorphous and crystalline technologies and their implications for drug delivery efficiency and...

DCB: does coating morphology matter for distal embolisation and clinical outcomes?

MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience

20 May 2026 – From EuroPCR 2026

This session examines the clinical evidence and experiential insights regarding the MagicTouch sirolimus-coated balloon (SCB) for treating coronary and peripheral artery disease. It reviews long-term comparative data versus paclitaxel-coated balloons, application techniques, integration into current practices, and findings from major trials such as SIRONA and SIMPLE-DM,...

MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience

Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection

20 May 2026 – From EuroPCR 2026

This session elucidates the role of non-invasive coronary CT and angiography-derived physiology in guiding lesion selection for drug-eluting balloon PCI. It emphasises integrating anatomical and physiological data to refine lesion preparation, strategy, and validation beyond angiography, and identifies scenarios where DEB PCI may not be optimal,...

Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection

Remaining challenges and role of innovative DES technology in complex PCI

20 May 2026 – From EuroPCR 2026

What still limits optimal outcomes in complex PCI, and how can current tools help overcome these barriers? Through three detailed case-based discussions, this EuroPCR 2026 session explores challenging clinical scenarios, including CTO, left main bifurcation, and complex PCI in a diabetic patient.

Each case highlights how advanced...

Remaining challenges and role of innovative DES technology in complex PCI

PRISM-PCI - From clarity to cure

20 May 2026 – From EuroPCR 2026

PRISM-PCI offers cutting-edge imaging innovations and treatment strategies aimed at optimizing complex PCI procedures. This session explores the 'leave nothing behind' concept with thin-strut bioresorbable scaffolds and sirolimus drug-coated balloons, updates on ultra thin-strut DES platforms, including the SORT OUT XII trial, and introduces a comprehensive...

PRISM-PCI - From clarity to cure

High definition IVUS-guided treatment strategies in calcified stenoses

20 May 2026 – From EuroPCR 2026

Severely calcified coronary stenoses remain one of the most challenging subsets in contemporary PCI, requiring precise lesion assessment and tailored treatment strategies.

This EuroPCR 2026 session focuses on how high-definition intravascular ultrasound (IVUS) is changing the way these lesions are approached in daily practice.

HD-IVUS enables detailed detection...

High definition IVUS-guided treatment strategies in calcified stenoses

DK Score Pro in focus: innovation, evidence, and everyday practice

20 May 2026 – From EuroPCR 2026

Watch this EuroPCR 2026 session to better understand how lesion preparation strategies can be optimised in complex PCI using directional scoring balloon technology with DK Score Pro.

Clinical evidence is reviewed, including insights from the SCORE CHINA registry, alongside practical considerations for integrating this approach into routine...

DK Score Pro in focus: innovation, evidence, and everyday practice